80 FR 232 pgs. 75692-75693 - Importer of Controlled Substances Registration: Catalent CTS, LLC
Type: NOTICEVolume: 80Number: 232Pages: 75692 - 75693
Pages: 75692, 75693Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2015-30551 Filed 12-2-15; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Catalent CTS, LLC
ACTION:
Notice of registration.
SUMMARY:
Catalent CTS, LLC applied to be registered as an importer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Catalent CTS, LLC registration as an importer of this controlled substance.
SUPPLEMENTARY INFORMATION:
By notice dated August 21, 2015, and published in the Federal Register on August 31, 2015, 80 FR 52509, Catalent CTS, LLC, 10245 Hickman Mills Drive, Kansas City, Missouri 64137 applied to be registered as an importer of a certain basic class of controlled substance. No comments or objections were submitted for this notice.
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Catalent CTS, LLC to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of marihuana (7360), a basic class of controlled substance listed in schedule I.
The company plans to import finished pharmaceutical products containing cannabis extracts in dosage form for clinical trial studies.
This compound is listed under drug code 7360. No other activity for this drug code is authorized for this registration. Approval of permits applications will occur only when the registrant's business activity is consistent with what is authorized under to 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale.
[top]
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015-30551 Filed 12-2-15; 8:45 am]
BILLING CODE 4410-09-P